Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?

[1]  M. Muscaritoli,et al.  Changes in Myostatin Signaling in Non-Weight-Losing Cancer Patients , 2012, Annals of Surgical Oncology.

[2]  S. Anker,et al.  Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference , 2012, Journal of cachexia, sarcopenia and muscle.

[3]  N. Paik,et al.  Association between muscle strength and metabolic syndrome in older Korean men and women: the Korean Longitudinal Study on Health and Aging. , 2012, Metabolism: clinical and experimental.

[4]  Y. Boirie,et al.  Toward a definition of sarcopenia. , 2011, Clinics in geriatric medicine.

[5]  G. Onder,et al.  Current and future pharmacologic treatment of sarcopenia. , 2011, Clinics in geriatric medicine.

[6]  Luigi Ferrucci,et al.  Sarcopenia with limited mobility: an international consensus. , 2011, Journal of the American Medical Directors Association.

[7]  T. Hawke,et al.  Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms , 2011, Pediatric diabetes.

[8]  Paula Ravasco,et al.  Definition and classification of cancer cachexia: an international consensus. , 2011, The Lancet. Oncology.

[9]  M. Muscaritoli,et al.  The “parallel pathway”: a novel nutritional and metabolic approach to cancer patients , 2011, Internal and emergency medicine.

[10]  D. Fouque,et al.  Use of handgrip strength in the assessment of the muscle function of chronic kidney disease patients on dialysis: a systematic review. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  J. Carrero,et al.  Increased expression of pro‐inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients , 2011, Journal of internal medicine.

[12]  M. Muscaritoli,et al.  β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. , 2011, International journal of oncology.

[13]  S. Anker,et al.  Myopenia—a new universal term for muscle wasting , 2011, Journal of cachexia, sarcopenia and muscle.

[14]  D. Volkert,et al.  Protein requirements in the elderly. , 2011, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[15]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[16]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[17]  D. Marks,et al.  Neuropeptides in the pathophysiology and treatment of cachexia , 2010, Current opinion in supportive and palliative care.

[18]  D. Choi,et al.  The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the Korean Sarcopenic Obesity Study (KSOS) , 2010, Clinical endocrinology.

[19]  M. Muscaritoli,et al.  Muscle atrophy in experimental cancer cachexia: Is the IGF‐1 signaling pathway involved? , 2010, International journal of cancer.

[20]  Stephan von Haehling,et al.  Cachexia as a major underestimated and unmet medical need: facts and numbers , 2010, Journal of cachexia, sarcopenia and muscle.

[21]  Nicola Maffulli,et al.  Sarcopenia: characteristics, mechanisms and functional significance. , 2010, British medical bulletin.

[22]  Isabel Azevedo,et al.  Chronic Inflammation in Obesity and the Metabolic Syndrome , 2010, Mediators of inflammation.

[23]  L. Ferrucci,et al.  Nutritional recommendations for the management of sarcopenia. , 2010, Journal of the American Medical Directors Association.

[24]  V. Kim,et al.  Pathogenesis of inflammation and repair in advanced COPD. , 2010, Seminars in respiratory and critical care medicine.

[25]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[26]  G. Biolo,et al.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". , 2010, Clinical nutrition.

[27]  W. Mitch,et al.  Review of muscle wasting associated with chronic kidney disease. , 2010, The American journal of clinical nutrition.

[28]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[29]  J. Michel,et al.  Understanding sarcopenia as a geriatric syndrome , 2010, Current opinion in clinical nutrition and metabolic care.

[30]  M. Polkey,et al.  The prevalence of quadriceps weakness in COPD and the relationship with disease severity , 2009, European Respiratory Journal.

[31]  I. Rahman,et al.  Current concepts on the role of inflammation in COPD and lung cancer. , 2009, Current opinion in pharmacology.

[32]  L. Kuller,et al.  Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes , 2009, Diabetes Care.

[33]  M. Tisdale.  Mechanisms of cancer cachexia. , 2009, Physiological reviews.

[34]  M. Sarnak,et al.  Does inflammation fuel the fire in CKD? , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  M. Fu.  Inflammation in chronic heart failure: what is familiar, what is unfamiliar? , 2009, European journal of heart failure.

[36]  M. Goto.  Inflammaging (inflammation + aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? , 2008, Bioscience trends.

[37]  S. Allison,et al.  Basics in clinical nutrition: Simple and stress starvation , 2008 .

[38]  P. Ponikowski,et al.  Cachexia: a new definition. , 2008, Clinical nutrition.

[39]  R. Wolfe,et al.  Optimal protein intake in the elderly. , 2008, Clinical nutrition.

[40]  J. E. Morley,et al.  Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives , 2008, The journal of nutrition, health & aging.

[41]  R. Parish,et al.  Inflammation in Chronic Heart Failure , 2008, The Annals of pharmacotherapy.

[42]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[43]  B. Tan,et al.  Cachexia: prevalence and impact in medicine , 2008, Current opinion in clinical nutrition and metabolic care.

[44]  A. Rossi,et al.  Sarcopenic obesity: a new category of obesity in the elderly. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[45]  Jenny Lee,et al.  Associated Factors and Health Impact of Sarcopenia in Older Chinese Men and Women: A Cross-Sectional Study , 2007, Gerontology.

[46]  David R. Thomas,et al.  Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. , 2007, Clinical nutrition.

[47]  Claude Pichard,et al.  Nutritional intervention and quality of life in adult oncology patients. , 2007, Clinical nutrition.

[48]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[49]  C. Stewart,et al.  Waste management - cytokines, growth factors and cachexia. , 2006, Cytokine & growth factor reviews.

[50]  E. Wouters,et al.  Body composition and mortality in chronic obstructive pulmonary disease. , 2005, The American journal of clinical nutrition.

[51]  A. Vigano,et al.  Quality of life and survival prediction in terminal cancer patients , 2004, Cancer.

[52]  L. Ferrucci,et al.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[53]  Ronenn Roubenoff,et al.  The Healthcare Costs of Sarcopenia in the United States , 2004, Journal of the American Geriatrics Society.

[54]  A. Laviano,et al.  Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. , 2003, The Lancet. Oncology.

[55]  K. Lemley,et al.  Determinants of glomerular hypofiltration in aging humans. , 2003, Kidney international.

[56]  P. Costelli,et al.  Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP‐ubiquitin‐dependent proteolysis , 2003, Current opinion in clinical nutrition and metabolic care.

[57]  R. Roubenoff.  Catabolism of aging: is it an inflammatory process? , 2003, Current opinion in clinical nutrition and metabolic care.

[58]  L. Bouter,et al.  How to measure comorbidity. a critical review of available methods. , 2003, Journal of clinical epidemiology.

[59]  M. Tisdale.  The 'cancer cachectic factor' , 2003, Supportive Care in Cancer.

[60]  M. Narici,et al.  Microgravity as a model of ageing , 2003, Current opinion in clinical nutrition and metabolic care.

[61]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[62]  A. Vigano,et al.  Survival prediction in terminal cancer patients: a systematic review of the medical literature , 2000, Palliative medicine.

[63]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[64]  N. Hollenberg,et al.  Age, Renal Perfusion and Function in Island-Dwelling Indigenous Kuna Amerinds of Panama , 1999, Nephron.

[65]  C. Hoffman,et al.  Persons with chronic conditions. Their prevalence and costs. , 1996, JAMA.

[66]  P. Rochon,et al.  Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. , 1996, Medical care.

[67]  M. Tisdale.  Cancer cachexia. , 1991, British Journal of Cancer.

[68]  L. Wesson.  Physiology of the Human Kidney , 1970 .

[69]  R. Ch.,et al.  NUTRITION IN GERIATRICS. , 1963 .

[70]  D F DAVIES,et al.  Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. , 1950, The Journal of clinical investigation.

[71]  S. Allison,et al.  Influence of malnutrition on function , 2011 .

[72]  S. Blankenberg,et al.  Inflammatory markers and cardiovascular risk in the metabolic syndrome. , 2011, Frontiers in bioscience.

[73]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[74]  J. López-Novoa,et al.  Physiology of the Healthy Aging Kidney , 2008 .

[75]  D. Oreopoulos,et al.  The Aging Kidney in Health and Disease , 2008 .

[76]  G. Mantovani,et al.  Cachexia related to multiple causes , 2006 .

[77]  Rocco Barazzoni,et al.  Metabolic consequences of physical inactivity. , 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[78]  D. Cella,et al.  Re-validation and Shortening of the Functional Assessmentof Anorexia/Cachexia Therapy (FAACT) Questionnaire , 2004, Quality of Life Research.

[79]  S. Allison,et al.  Basics in Clinical Nutrition , 2004 .

[80]  A. Schols.  Pulmonary cachexia. , 2002, International journal of cardiology.

[81]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[82]  Sj Wu,et al.  A Projection of Chronic Illness Prevalence and Cost Inflation , 2000 .

[83]  K Bandeen-Roche,et al.  Association of comorbidity with disability in older women: the Women's Health and Aging Study. , 1999, Journal of clinical epidemiology.

[84]  P. L. Fur,et al.  Santé, soins et protection sociale en 1998 , 1998 .

[85]  Bernard L. Strehler,et al.  Time, cells, and aging , 1962 .